![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sireesh Appajosyula
Directeur/Bestuurslid bij
HEPION PHARMACEUTICALS, INC.
Vermogen: 265 982 $ op 30-06-2026
Profiel
Sireesh Appajosyula currently works at Hepion Pharmaceuticals, Inc., as Director from 2026, Highpoint Pharmaceuticals LLC, as Managing Member from 2018, and Channel Bioconsulting LLC, as Managing Partner from 2015.
Dr. Appajosyula also formerly worked at Canton Strategic Holdings, Inc., as Chief Financial Officer in 2025, 9 Meters Biopharma, Inc., as SVP-Corporate Development & Operations, and Salix Pharmaceuticals, Inc., as Head-Business Development.
Dr. Appajosyula received his undergraduate degree from Rutgers State University of New Jersey and doctorate degree from Ernest Mario School of Pharmacy.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 64.178 ( 0,08% ) | 180 982 $ | 30-06-2026 | |
| 28-04-2026 | 1.250.000 ( 4,29% ) | 85 000 $ | 30-06-2026 |
Actieve functies van Sireesh Appajosyula
| Bedrijven | Functie | Begin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 16-03-2026 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01-01-2018 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 01-01-2015 |
Eerdere bekende functies van Sireesh Appajosyula
| Bedrijven | Functie | Einde |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Algemeen Directeur | - |
| 9 METERS BIOPHARMA, INC. | Operationeel Directeur | 17-07-2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Opleiding van Sireesh Appajosyula
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
